TECHNOLOGY, SCIENCE AND COLLABORATION
For Patients and their Families
Here you will find useful information about clinic, our doctors, booking an appointment…
For Health Professionals
Find out useful information about our doctors, case studies….
Sydney Retina and the Sydney Institute of Vision Science are actively involved in clinical trials which facilitate not only new drugs but existing drugs becoming available for a wider range of indications. Existing drugs approved for new indications means that drugs that were previously not accessible can now be used and are now PBS subsidised.
An orange a day keeps the macular degeneration away.
Sydney Retina is committed to ensuring that your privacy and medical records are secure.Read more
Scientific Journal Publications
2018 Chang A, Kawasaki R, – Asia Pacific-Technology and Trend Survey. APJO (In Press) Spooner K, Bahrami B,
Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration.Read more
Acta Ophthalmol. 2014 Dec;92(8):713-23. doi: 10.1111/aos.12463. Epub 2014 Jun 12. Broadhead GK 1 , Hong T, Chang AA.
Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes.Read more
Graefes Arch Clin Exp Ophthalmol. 2015 Aug;253(8):1217-25. doi: 10.1007/s00417-014-2799-8. Epub 2014 Sep 10. Zhu M 1 , Chew